Source
Tidsskr Nor Laegeforen. 1998 Dec 10;118(30):4637-41
Publication Type
Article
Date
Dec-10-1998
Author
O. Spigset
Author Affiliation
Avdeling for legemidler, Regionsykehuset i Trondheim.
Source
Tidsskr Nor Laegeforen. 1998 Dec 10;118(30):4637-41
Date
Dec-10-1998
Language
Norwegian
Publication Type
Article
Keywords
Advertising as Topic - standards
Databases, Bibliographic
Drug Information Services - standards
Humans
Legislation, Drug
Norway
Quality Control
Serial Publications
Serotonin Uptake Inhibitors - therapeutic use
Abstract
In order to assess the quality of pharmaceutical advertising in Norway, we conducted a review of advertisements for selective serotonin re-uptake inhibitors published in the Journal of the Norwegian Medical Association and the journal Legemidler og samfunn during the period 1995-97. 18 advertisements with 38 reference citations were identified. In six citations (16%), errors made it impossible to identify the source with certainty solely on the basis of the advertisement. Under Norwegian drug advertisement regulations, a total of 56 statements should have been followed by a reference citation. In 18 of these (33%), it was debatable whether the statements were in accordance with the regulations. This review indicates that a significant proportion of the statements in drug advertisements is inaccurate and gives a too positive picture of the properties of the drug.
PubMed ID
9914744 View in PubMed
Less detail